"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT01558635","Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation","CRYO-AF","Terminated","Has Results","Longstanding Persistent Atrial Fibrillation","Device: Cardioblate CryoFlex Surgical Ablation|Procedure: Mitral Valve surgery|Device: Medtronic Reveal XT Insertable Cardiac Monitor|Procedure: MAZE III","Efficacy: Percentage of Treated Subjects Diagnosed With Longstanding Persistent AF Off Class I or III Antiarrhythmic Drugs and Out of AF at 12 Months, and Who Did Not Receive Additional Ablation Therapy for AF Prior to the 12-month Evaluation.|Safety: Rate of Device and Procedure Related Acute Major Adverse Events (MAE) Within 30 Days Post-procedure or Prior to Hospital Discharge, Whichever Came Last|Number of Participants With Freedom From AF Regardless of Use of Anti-Arrhythmic Drugs|AF Burden in Subjects Diagnosed With Longstanding Persistent AF as Measured by Reveal XT Recordings at 3, 6 and 12 Months|Assessment of Quality of Life as Measured by the SF-12 at Baseline, 6 and 12 Months After the Procedure|Rate of Device and Procedure Related Acute Major Adverse Events (MAE) Within 12 Months Post-procedure or Prior to Hospital Discharge, Whichever Came Last","Medtronic Bakken Research Center|Medtronic Cardiovascular","All","18 Years and older Â  (Adult, Older Adult)","Not Applicable","17","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MDT-CRYO-001","November 2011","January 2016","January 2016","March 20, 2012","March 1, 2019","July 30, 2019","Herzzentrum Leipzig GmbH, Leipzig, Germany|Sheba Medical Center, Tel-Hashomer, Israel|San Raffaele Hospital, Milan, Italy|Hospital Clinic de Barcelona, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT01558635"
